Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin

Doxorubicin is a first-line therapy for patients with unresectable advanced soft tissue sarcoma (STS). However, because of cardiotoxicities, it is not used for patients with cardiac problems. Eribulin has exhibited efficacy for advanced STS in second- or later-line treatments. In the present study,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Tsuchihashi, Kenji, Kusaba, Hitoshi, Yoshihiro, Tomoyasu, Fujiwara, Toshifumi, Setsu, Nokitaka, Endo, Makoto, Matsumoto, Yoshihiro, Imajima, Takashi, Shinohara, Yudai, Ito, Mamoru, Yamaga, Satoru, Tanoue, Kenro, Arimizu, Kohei, Ohmura, Hirofumi, Hanamura, Fumiyasu, Yamaguchi, Kyoko, Isobe, Taichi, Ariyama, Hiroshi, Nakashima, Yasuharu, Akashi, Koichi, Baba, Eishi
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7708971/
https://ncbi.nlm.nih.gov/pubmed/33262403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-77898-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky